amprenavir has been researched along with Acquired Immunodeficiency Syndrome in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bates, SM; Nakielny, RA; Page, KB; Talbot, MD | 1 |
| Bacconier, J; Basso, S; Durand, A; Lacarelle, B; Poizot-Martin, I; Quinson, AM; Ravaux, I; Solas, C | 1 |
| Deray, G; Izzedine, H; Janus, N; Karie, S; Launay-Vacher, V; Laville, I | 1 |
| Livington, DJ; Painter, GR; Partaledis, JA; Pazhanisamy, S; Porter, DJ; Tung, RD | 1 |
| Baggett, TH; Gracia Jones, S | 1 |
| Heinrikson, RL; Tomasselli, AG | 1 |
| Koch, CA; Wolkersdoerfer, G | 1 |
| Caldwell, P; Furlan, S; Ho, D; Hurley, A; Johnson, J; Kost, RG; Markowitz, M; Smiley, L; Talal, A; Vesanen, M; Zhang, L | 1 |
| Levin, J | 1 |
| Agosto, M | 1 |
| Bart, PA; Baumann, P; Eap, CB; Gallant, S; Golay, KP; Pantaleo, G; Rizzardi, PG | 1 |
2 review(s) available for amprenavir and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Clinical update: new drugs for HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; Chemistry, Pharmaceutical; Cyclopropanes; Dideoxynucleosides; Drug Approval; Furans; HIV Protease Inhibitors; Humans; Organophosphonates; Oxazines; Reverse Transcriptase Inhibitors; Sulfonamides | 1999 |
Targeting the HIV-protease in AIDS therapy: a current clinical perspective.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Binding Sites; Carbamates; Clinical Trials as Topic; Computer-Aided Design; Crystallography, X-Ray; Drug Design; Drug Resistance, Microbial; Drug Therapy, Combination; Furans; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Nelfinavir; Oligopeptides; Pyridines; Pyrones; Randomized Controlled Trials as Topic; Ritonavir; Saquinavir; Sulfonamides | 2000 |
2 trial(s) available for amprenavir and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1--infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; Chronic Disease; Dideoxynucleosides; Digestive System; Drug Synergism; Ethnicity; Female; Furans; HIV Infections; HIV-1; Humans; Lamivudine; Lymphocyte Subsets; Male; Pregnancy; Research Design; RNA, Viral; Sulfonamides; Treatment Refusal; Zidovudine | 2001 |
Protease inhibitor trial started.
Topics: Acquired Immunodeficiency Syndrome; Adult; Carbamates; Furans; HIV Protease Inhibitors; Humans; Indinavir; Reverse Transcriptase Inhibitors; Sulfonamides | 1998 |
9 other study(ies) available for amprenavir and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Cushing's syndrome mimicking lipodystrophy syndrome in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Carbamates; Cushing Syndrome; Diagnosis, Differential; Drug Therapy, Combination; Furans; HIV Protease Inhibitors; Humans; Lipodystrophy; Male; Megestrol Acetate; Reverse Transcriptase Inhibitors; Sulfonamides | 2002 |
Pharmacokinetic interaction between lopinavir/r and amprenavir in salvage therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Carbamates; Drug Interactions; Female; Furans; HIV-1; Humans; Lopinavir; Male; Middle Aged; Pyrimidinones; Retrospective Studies; Salvage Therapy; Sulfonamides | 2002 |
[Pharmacokinetics of amprenavir in HIV-1 patients with renal insufficiency].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Carbamates; Female; Furans; Humans; Kidney Function Tests; Male; Middle Aged; Renal Insufficiency; Sulfonamides | 2007 |
Weak binding of VX-478 to human plasma proteins and implications for anti-human immunodeficiency virus therapy.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Blood; Blood Proteins; Carbamates; Cattle; Fetus; Furans; HIV Protease Inhibitors; Humans; Kinetics; Molecular Structure; Orosomucoid; Protein Binding; Spectrophotometry, Ultraviolet; Sulfonamides | 1995 |
[Hyperlipoproteineumia in HIV patients undergoing antiretroviral therapy: which risk is greater--pancreatitis or coronary disease?].
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Anti-HIV Agents; Carbamates; Coronary Disease; Dideoxynucleosides; Drug Therapy, Combination; Furans; Hepatitis B; HIV Protease Inhibitors; Humans; Hyperlipoproteinemias; Male; Middle Aged; Pancreatitis; Risk Factors; Ritonavir; Sulfonamides | 2000 |
Abacavir (1592) with protease inhibitors in potent antiretroviral activity.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Carbamates; Dideoxynucleosides; Drug Therapy, Combination; Furans; HIV Protease Inhibitors; Humans; Indinavir; Nelfinavir; Ritonavir; Saquinavir; Sulfonamides; Viral Load | 1998 |
Protease inhibitors and prevention of cross resistance.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Carbamates; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoquinolines; Lamivudine; Nelfinavir; Pyridines; Quinolines; Saquinavir; Sulfonamides; Zalcitabine; Zidovudine | 1995 |
Moving forward: a treatment overview from the 12th World AIDS Conference.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; CD4-Positive T-Lymphocytes; Clinical Trials as Topic; Congresses as Topic; Cyclopropanes; Dideoxynucleosides; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Furans; Health Services Accessibility; HIV Protease Inhibitors; Humans; Hydroxyurea; Lopinavir; Oxazines; Patient Care Planning; Pyrimidinones; Remission Induction; Reverse Transcriptase Inhibitors; Sulfonamides; Switzerland; Virus Replication | 1998 |
Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir.
Topics: Acquired Immunodeficiency Syndrome; Analgesics, Opioid; Carbamates; Dideoxynucleosides; Drug Interactions; Drug Therapy, Combination; Furans; HIV Protease Inhibitors; HIV-1; Humans; Methadone; Reverse Transcriptase Inhibitors; Substance-Related Disorders; Sulfonamides | 2001 |